SCHEMBL14565632

SCHEMBL14565632

CCOC(=O)c1cc2ccccc2n1CCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.59
CRHBP P24387 1/20 0.59
CRHR2 Q13324 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
NOD2 Q9HC29 6/20 0.56
NOD1 Q9Y239 6/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
F10 P00742 2/20 0.50
MTNR1A P48039 1/20 0.47
MTNR1B P49286 1/20 0.47
SRC P12931 1/20 0.43
CNR2 P34972 1/20 0.42
MCL1 Q07820 1/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 2/20 0.41
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31486613 0.94 KDM4E (0.57) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL14565663 0.86 ALDH1A1 (0.55) KDM4ECRHBPCRHR2SMN1; SMN2MEN1
SCHEMBL9940446 0.80 SMN1; SMN2 (0.42) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL31486847 0.80 KDM4E (0.42) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL6752352 0.80 KDM4E (0.71) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL15303078 0.79 NTRK1 (0.44) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL6750639 0.79 KDM4E (0.64) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL18322286 0.78 KDM4E (0.73) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL13742183 0.78 KDM4E (0.70) KDM4ECRHBPCRHR2SMN1; SMN2NOD2
SCHEMBL30489155 0.78 KDM4E (0.73) KDM4ECRHBPCRHR2SMN1; SMN2NOD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453801-B1 SUBSTITUTED 2-AMINO-CYCLOALKANECARBOXAMIDES AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP disclosed